Piramal Pharma Solutions (PPS), a portfolio company of the India-based Piramal Group, is a CDMO that provides end-to-end development and manufacturing solutions across the drug product life cycle. Included in their small molecule services are drug discovery solutions, process development, clinical trial supplies, commercial supply of APIs, and finished dosage forms. PPS also offers specialized services, including HPAPI development and manufacturing, sterile fill/finish, peptide products and services, and potent solid oral drug product support. The company maintains multiple facilities across India, the UK, the U.S., and Canada.
